Tribute to Dr. Stephen Harrison

Tribute to Dr. Stephen Harrison

April 27, 2024 | By

Chandler, AZ, April 27, 2024 / Today, we remember and honor a truly remarkable individual and dear friend, Dr. Stephen Harrison, whose first and foremost love was his family and especially his two children who were his pride and joy.  We …

Vicki McIntyre, DNP,FNP featured on Tucson’s Morning Blend

Vicki McIntyre, DNP,FNP featured on Tucson’s Morning Blend

January 6, 2020 | By | Appearances

AZ Liver’s own Vicki McIntyre, DNP, FNP was featured on the popular Tucson morning show “The Morning Blend” last month where she discussed several topics including:

AZ Liver Unveils Mega Liver at Tucson Health and Wellness Expo

AZ Liver Unveils Mega Liver at Tucson Health and Wellness Expo

November 1, 2019 | By | Education

As part of its mission to educate the community about liver health, AZ Liver Health has created a large, inflatable educational tool to bring the liver to life. The nearly 12-foot tall liver highlights the major anatomy of the liver …

PubMed Logo

New Treatment for PBC Liver: Practical Strategies for Pruritus Management

April 8, 2019 | By | Publications

This article provides expert guidance on the management of pruritus symptoms in patients receiving obeticholic acid (OCA) as treatment for primary biliary cholangitis (PBC).

PubMed Logo

Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma?

April 8, 2019 | By | Publications

In this review we critically assess the literature to evaluate the level of risk posed by alcohol as both a primary etiology of hepatocellular carcinoma (HCC) and

JAMA network red

Treatment of Hepatitis C A Systematic Review

April 8, 2019 | By | Publications

Abstract: Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler therapeutics using direct-acting antivirals that target various stages of the HCV life cycle are in development to eradicate HCV without concomitant interferon.

AIM

Re-treatment of Chronic HCV Genotype 1 Infection After Relapse | Annals of Internal Medicine | American College of Physicians

April 8, 2019 | By | Publications

The interferon (IFN)–free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to treat chronic hepatitis C virus (HCV) genotype 1 (GT-1) infection for patients ineligible for IFN. However, sofosbuvir plus ribavirin therapy is associated with relapse in 15% to 30% of patients with HCV GT-1.

Liver Disease and Advances in Screening Technology YouTube

Liver Disease and Advances in Screening Technology

April 5, 2019 | By | Presentations, Video Lectures

Our very own Ann Moore joins Wayne Eskridge to discuss advances in liver disease screening technology.

Healthy Liver Diet: Liver Disease Diet from Liver Foundation

Healthy Liver Diet: Liver Disease Diet from Liver Foundation

March 22, 2019 | By | Publications

If you’re a liver patient, your diet is adjusted to meet your individual needs. Talk to your doctor about what’s best for you. Still, here are some general food tips for a healthy or healthier liver:

The GP Show (Podcast)

The GP Show (Podcast)

March 22, 2019 | By | Podcasts

Join GP and Medical Educator Dr Sam Manger MBBS BSc FRACGP FASLM covering a variety of topics with case studies, guideline reviews, guest interviews and more for medical doctors and allied…